IGM BIOSCIENCES INC (IGMS)

US4495851085 - Common Stock

7.65  -0.31 (-3.89%)

After market: 7.65 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
2.13M1.07M0.000.000.00
Operating Expenses
265.59M229.03M165.32M83.28M44.50M
Research and Development
215.52M179.29M127.03M65.03M35.26M
Selling, General, and Administrative Expenses
50.07M49.74M38.30M18.25M9.24M
Operating Income
-263.46M-227.96M-165.32M-83.28M-44.50M
Interest Income/Expense
17.74M7.04MN/AN/AN/A
Other Income/Expense
-20.00K-180.00K160.00K1.93M1.37M
Income Before Taxes
-245.74M-221.10M-165.16M-81.36M-43.13M
Income Tax
678.00KN/AN/AN/AN/A
Net Income
-246.42M-221.10M-165.16M-81.36M-43.13M
EBITDA
-255.18M-221.88M-160.84M-82.25M-43.90M
 
Per Share Data
EPS Diluted Total Ops
-4.71-5.32-4.93-2.65-1.41
Non GAAP EPS
-4.81-5.37-4.93-2.65N/A
 
Statistics
Profit Margin
-11568.83%-20663.55%N/AN/AN/A
Operating Profit Margin
-12369.06%-21304.67%N/AN/AN/A

All data in USD

Charts